Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis

Abstract Purpose Oncologists, clinical trialists, and guideline developers need tools that enable them to efficiently review the settings and results of previous studies testing metastatic breast cancer (MBC) drug therapies....

全面介绍

书目详细资料
Main Authors: Silberholz, John, Bertsimas, Dimitris, Vahdat, Linda
格式: 文件
语言:English
出版: Springer US 2021
在线阅读:https://hdl.handle.net/1721.1/131911